Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer.
暂无分享,去创建一个
J. Ciezki | C. Reddy | E. Klein | S. Campbell | A. Stephenson | J. Ulchaker | K. Stephans | R. Tendulkar | K. Angermeier | J. Kittel | Kristin L. Smith | D. Wilkinson | Chandana A. Reddy